
New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Struggling with early onset dementia, Greg Kelly traveled from Australia to Denmark to see what life would be like in a dementia village. He was surprised by what he saw.

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

Researchers find people living in towns with lots of green space were least likely to have Alzheimer’s or Parkinson’s.

Taking a daily multivitamin supplement can slow age-related memory decline, researchers found.

Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.

Canada’s first dementia village enables its inhabitants to live their lives in freedom and dignity, while ensuring they have person-centered care. Learn more.

Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.

Dementia incidence has steadily fallen by 20 to 25 percent over the past three decades in the U.S., U.K., Sweden, and the Netherlands. How come?

What are the six signs of early dementia, and how can Vitamin B1 help head it off? Dr. Eric Berg explains.

Learn about ‘personalized music for dementia’ and its powerful effect on Alzheimer’s. See the Director of the hit film, ‘Alive Inside’, on the dementia-impact of music.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Dr. Richard Taylor has Alzheimer’s and the right attitude!

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.

Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.


